227 related articles for article (PubMed ID: 14530303)
1. Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.
Devaraj K; Gillison ML; Wu TC
Crit Rev Oral Biol Med; 2003; 14(5):345-62. PubMed ID: 14530303
[TBL] [Abstract][Full Text] [Related]
2. Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers.
Ling M; Kanayama M; Roden R; Wu TC
J Biomed Sci; 2000; 7(5):341-56. PubMed ID: 10971133
[TBL] [Abstract][Full Text] [Related]
3. Preventative and therapeutic vaccines for cervical cancer.
Roden R; Wu TC
Expert Rev Vaccines; 2003 Aug; 2(4):495-516. PubMed ID: 14711335
[TBL] [Abstract][Full Text] [Related]
4. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
5. Vaccination to prevent and treat cervical cancer.
Roden RB; Ling M; Wu TC
Hum Pathol; 2004 Aug; 35(8):971-82. PubMed ID: 15297964
[TBL] [Abstract][Full Text] [Related]
6. Papillomavirus-like particle vaccines.
Schiller JT; Lowy DR
J Natl Cancer Inst Monogr; 2001; (28):50-4. PubMed ID: 11158207
[TBL] [Abstract][Full Text] [Related]
7. Progress in prophylactic and therapeutic vaccines for human papillomavirus infection.
Stanley MA
Expert Rev Vaccines; 2003 Jun; 2(3):381-9. PubMed ID: 12903803
[TBL] [Abstract][Full Text] [Related]
8. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
Mahdavi A; Monk BJ
Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
[TBL] [Abstract][Full Text] [Related]
9. HPV DNA vaccines.
Moniz M; Ling M; Hung CF; Wu TC
Front Biosci; 2003 Jan; 8():d55-68. PubMed ID: 12456324
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.
Kaufmann AM; Stern PL; Rankin EM; Sommer H; Nuessler V; Schneider A; Adams M; Onon TS; Bauknecht T; Wagner U; Kroon K; Hickling J; Boswell CM; Stacey SN; Kitchener HC; Gillard J; Wanders J; Roberts JS; Zwierzina H
Clin Cancer Res; 2002 Dec; 8(12):3676-85. PubMed ID: 12473576
[TBL] [Abstract][Full Text] [Related]
11. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
12. Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer.
Zhai L; Yadav R; Kunda NK; Anderson D; Bruckner E; Miller EK; Basu R; Muttil P; Tumban E
Antiviral Res; 2019 Jun; 166():56-65. PubMed ID: 30926288
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus genotype 16 vaccines for cervical cancer prophylaxis and treatment.
Cornelison TL
Curr Opin Oncol; 2000 Sep; 12(5):466-73. PubMed ID: 10975555
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus vaccines for the prevention and treatment of cervical cancer.
Tomson TT; Roden RB; Wu TC
Curr Opin Investig Drugs; 2004 Dec; 5(12):1247-61. PubMed ID: 15648945
[TBL] [Abstract][Full Text] [Related]
15. Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model.
Monroy-García A; Gómez-Lim MA; Weiss-Steider B; Hernández-Montes J; Huerta-Yepez S; Rangel-Santiago JF; Santiago-Osorio E; Mora García Mde L
Arch Virol; 2014 Feb; 159(2):291-305. PubMed ID: 23990055
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus vaccines.
Breitburd F; Coursaget P
Semin Cancer Biol; 1999 Dec; 9(6):431-44. PubMed ID: 10712890
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccines for cervical cancer: from bench to bedside.
Hung CF; Monie A; Alvarez RD; Wu TC
Exp Mol Med; 2007 Dec; 39(6):679-89. PubMed ID: 18160838
[TBL] [Abstract][Full Text] [Related]
18. Immunology of the human papilloma virus in relation to cancer.
Wu TC
Curr Opin Immunol; 1994 Oct; 6(5):746-54. PubMed ID: 7826530
[TBL] [Abstract][Full Text] [Related]
19. Animal models for development of therapeutic HPV16 vaccines (review).
Bubeník J
Int J Oncol; 2002 Jan; 20(1):207-12. PubMed ID: 11743666
[TBL] [Abstract][Full Text] [Related]
20. Variation of HPV Subtypes with Focus on HPV-Infection and Cancer in the Head and Neck Region.
Wichmann G
Recent Results Cancer Res; 2017; 206():113-122. PubMed ID: 27699533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]